Aimin Xu
Aimin Xu
Department of Medicine, Department of Pharmacology and Pharmacy, the University of Hong Kong
在 hku.hk 的電子郵件地址已通過驗證
標題
引用次數
引用次數
年份
The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice
A Xu, Y Wang, H Keshaw, LY Xu, KSL Lam, GJS Cooper
The Journal of clinical investigation 112 (1), 91-100, 2003
15152003
Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans
X Zhang, DCY Yeung, M Karpisek, D Stejskal, ZG Zhou, F Liu, RLC Wong, ...
Diabetes 57 (5), 1246-1253, 2008
7452008
Value-added utilisation of waste glass in concrete
A Shayan, A Xu
Cement and concrete research 34 (1), 81-89, 2004
7162004
Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome
A Xu, AWK Tso, BMY Cheung, Y Wang, NMS Wat, CHY Fong, ...
Circulation 115 (12), 1537-1543, 2007
563*2007
Adipocyte fatty acid–binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome
A Xu, Y Wang, JY Xu, D Stejskal, S Tam, J Zhang, NMS Wat, WK Wong, ...
Clinical chemistry 52 (3), 405-413, 2006
5492006
Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans
Y Wang, KSL Lam, EW Kraegen, G Sweeney, J Zhang, AWK Tso, ...
Clinical Chemistry 53 (1), 34-41, 2007
5262007
Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes
A Xu, KW Chan, RLC Hoo, Y Wang, KCB Tan, J Zhang, B Chen, MC Lam, ...
Journal of Biological Chemistry 280 (18), 18073-18080, 2005
5182005
Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin potential role in the modulation of its insulin-sensitizing activity
Y Wang, A Xu, C Knight, LY Xu, GJS Cooper
Journal of Biological Chemistry 277 (22), 19521-19529, 2002
5112002
Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation
KCB Tan, A Xu, WS Chow, MCW Lam, VHG Ai, SCF Tam, KSL Lam
The Journal of Clinical Endocrinology & Metabolism 89 (2), 765-769, 2004
4942004
Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner
Y Wang, KSL Lam, JY Xu, G Lu, LY Xu, GJS Cooper, A Xu
Journal of Biological Chemistry 280 (18), 18341-18347, 2005
4692005
Post-translational modifications of adiponectin: mechanisms and functional implications
Y Wang, KSL Lam, M Yau, A Xu
Biochemical Journal 409 (3), 623-633, 2008
4262008
Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice
Z Lin, H Tian, KSL Lam, S Lin, RCL Hoo, M Konishi, N Itoh, Y Wang, ...
Cell metabolism 17 (5), 779-789, 2013
4242013
Performance of glass powder as a pozzolanic material in concrete: A field trial on concrete slabs
A Shayan, A Xu
Cement and concrete research 36 (3), 457-468, 2006
3622006
Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice.
SA Shore, RD Terry, L Flynt, A Xu, C Hug
The Journal of allergy and clinical immunology 118 (2), 389, 2006
3532006
Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells
KKY Cheng, KSL Lam, Y Wang, Y Huang, D Carling, D Wu, C Wong, A Xu
Diabetes 56 (5), 1387-1394, 2007
3382007
Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study
WS Chow, BMY Cheung, AWK Tso, A Xu, NMS Wat, CHY Fong, LHY Ong, ...
Hypertension 49 (6), 1455-1461, 2007
3372007
The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology
X Ding, NK Saxena, S Lin, A Xu, S Srinivasan, FA Anania
The American journal of pathology 166 (6), 1655-1669, 2005
3312005
Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention
W Zhu, KKY Cheng, PM Vanhoutte, KSL Lam, A Xu
Clinical science 114 (5), 361-374, 2008
3112008
Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride
H Li, Q Fang, F Gao, J Fan, J Zhou, X Wang, H Zhang, X Pan, Y Bao, ...
Journal of hepatology 53 (5), 934-940, 2010
3082010
Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice
A Xu, MC Lam, KW Chan, Y Wang, J Zhang, RLC Hoo, JY Xu, B Chen, ...
Proceedings of the National Academy of Sciences 102 (17), 6086-6091, 2005
3042005
系統目前無法執行作業,請稍後再試。
文章 1–20